News
EnVVENO Medical To Present Topline Efficacy Data Showing Clinical Improvement From VenoValve Pivotal Trial At VENOUS2024 American Venous Forum Annual Meeting
6 Mar 24
Biotech, News, Events, General
Recap: enVVeno Medical Q4 Earnings
29 Feb 24
Earnings
enVVeno Medical Q4 EPS $(0.32) Beats $(0.46) Estimate
29 Feb 24
Earnings, News
Press releases
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
24 Apr 24
Biotech, News, Press Releases
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
16 Apr 24
Biotech, News, Press Releases
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
9 Apr 24
Biotech, Management, Press Releases
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
6 Mar 24
Biotech, News, Press Releases